UNIVERSITY OF KENT Researchers from the University of Kent in Canterbury, UK and the Goethe-University in Frankfurt am Main have identified new therapies for COVID-19 that could provide better protection against future variants and outbreaks. An international team led by Professor Martin Michaelis, Professor Mark Wass (both School of Biosciences, University of Kent), and Professor...
Tag: <span>COVID-19 treatments</span>
Post
AI tool pairs protein pathways with clinical side effects, patient comorbidities to suggest targeted Covid-19 treatments
GEORGIA INSTITUTE OF TECHNOLOGY IMAGE: THIS COLORIZED TRANSMISSION ELECTRON MICROGRAPH SHOWS SARS-COV-2 VIRUS PARTICLES (ORANGE), ISOLATED FROM A PATIENT. CREDIT: NIAID VIA NIH CREDIT: NIAID VIA NIH The symptoms and side effects of Covid-19 are scattered across a diagnostic spectrum. Some patients are asymptomatic or experience a mild immune response, while others report significant long-term...
Post
Remdesivir and interferon fall flat in WHO’s mega study of COVID-19 treatments
Patients get tested for COVID-19 in India, one of 30 countries that took part in the Solidarity trial. One of the world’s biggest trials of COVID-19 therapies released its long-awaited interim results yesterday—and they’re a letdown. None of the four treatments in the Solidarity trial, which enrolled more than 11,000 patients in 400 hospitals around...
Post
New process to identify existing drugs for potential COVID-19 treatments
by Adrian De Novato, Michigan State University In late January, as the world watched the growing COVID-19 epidemic with increasing unease, a Michigan State University laboratory, which specializes in the use of artificial intelligence and big data to discover therapeutics for cancers, switched gears to face the coming challenge. The Chen Lab, led by Bin...